1-(2-methoxyethyl)-1H-pyrrolo[2,3-b]pyridine | 418795-27-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯并吡啶类
• 英文名称: 1-(2-methoxyethyl)-1H-pyrrolo[2,3-b]pyridine
• 英文别名: 1-(2-methoxyethyl)pyrrolo[2,3-b]pyridine
• CAS: 418795-27-4
• 化学式: C₁₀H₁₂N₂O
• 分子量: 176.218
• InChiKey: DVJSWLBTNLNJPH-UHFFFAOYSA-N

物化性质

• 沸点：
  303.6±22.0 °C(Predicted)
• 密度：
  1.11±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  27
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1-(2-methoxyethyl)-1H-pyrrolo[2,3-b]pyridine 在 palladium on activated charcoal 4-二甲氨基吡啶 、 manganese(IV) oxide 、 甲酸 、 TEA 、 N,N-二异丙基乙胺 、 三氟乙酸 作用下， 以 甲醇 、 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 5.0h， 生成
  参考文献：
  名称：

  强大的血小板衍生生长因子-β受体（PDGF-betaR）抑制剂：7- [3-（环己基甲基）脲基] -3- {1-甲基-1H-吡咯[2,3-b]的合成与构效关系] pyridin-3-yl} quinoxalin-2（1H）-one衍生物。

  摘要：

  我们先前发现7- [3-（环己基甲基）脲基] -3- {1-甲基-1H-吡咯并[2,3-b]吡啶-3-基}喹喔啉-2（1H）-一（7d-6 ）作为PDGF抑制剂具有相当大的潜力。该化合物在PDGF诱导的CPA（细胞增殖测定）和APA（自磷酸化测定）中表现出有效的抑制活性（C50中的IC50 = 0.05 micromol / l，APA中的0.03 micromol / l）。因此，我们试图通过优化其一系列衍生物来开发新颖有效的PDGF-βR抑制剂。我们发现三氟乙酸（TFA）催化吡咯并[2,3-b]吡啶与喹喔啉-2-酮的偶联在温和的氧化条件下有效地进行了氧化锰（IVO）的原位反应，因此该方法得以应用准备一系列衍生物。对新合成衍生物进行体外筛选的结果表明，化合物7d-9具有强效性（CPA中的IC50 = 0.014 micromol / l，APA中的0.007 micromol / l）和

  DOI：

  10.1248/cpb.55.255
• 作为产物：
  描述：

  7-氮杂吲哚 、 2-溴乙基甲基醚 在 sodium hydride 作用下， 以 N,N-二甲基甲酰胺 、 mineral oil 为溶剂， 反应 24.5h， 以81%的产率得到1-(2-methoxyethyl)-1H-pyrrolo[2,3-b]pyridine
  参考文献：
  名称：

  新型噻唑降钙素原类似物的合成，抗肿瘤活性和CDK1抑制作用

  摘要：

  方便地合成了一系列新的噻唑降钙素原类似物，总收率很高。测试了新衍生物对NCI全图的不同人类肿瘤细胞系的抗增殖活性。其中四个显示出良好的抗肿瘤活性，GI 50值从微摩尔到纳摩尔水平。这些衍生物的抗增殖作用的机制是促凋亡的，与质膜磷脂酰丝氨酸的外在化和DNA片段化有关。新噻唑类化合物中最具活性和选择性的是将活细胞限制在G2 / M期，并显着抑制了体外CDK1活性。

  DOI：

  10.1016/j.ejmech.2017.06.052

文献信息

• One-Pot Desulfonylative Alkylation of N-Sulfonyl Azacycles Using Alkoxides Generated by Phase-Transfer Catalysis
  作者：Justin Denton

  DOI：10.1055/s-0029-1218627

  日期：2010.3

  Sulfonamide heterocycles, specifically 3-acylindoles, undergo a deprotection/alkylation sequence in the presence of an appropriate alcohol when cesium carbonate or potassium carbonate and a phase-transfer catalyst are utilized. The outcome of the one-pot protocol was found to be significantly dependent on both the alcohol and sulfonamide heterocycle employed. Strictly anhydrous conditions are not necessary

  当使用碳酸铯或碳酸钾和相转移催化剂时，在合适的醇存在下，磺酰胺杂环，特别是3-酰基环，经历脱保护/烷基化序列。发现一锅法的结果很大程度上取决于所用的醇和磺酰胺杂环。严格的无水条件对于该方案不是必需的。 相转移催化-磺酰胺-杂环-裂解-烷基化
• An Orally Bioavailable, Indole-3-glyoxylamide Based Series of Tubulin Polymerization Inhibitors Showing Tumor Growth Inhibition in a Mouse Xenograft Model of Head and Neck Cancer
  作者：Helen E. Colley、Munitta Muthana、Sarah J. Danson、Lucinda V. Jackson、Matthew L. Brett、Joanne Harrison、Sean F. Coole、Daniel P. Mason、Luke R. Jennings、Melanie Wong、Vamshi Tulasi、Dennis Norman、Peter M. Lockey、Lynne Williams、Alexander G. Dossetter、Edward J. Griffen、Mark J. Thompson

  DOI：10.1021/acs.jmedchem.5b01312

  日期：2015.12.10

  A number of indole-3-glyoxylamides have previously been reported as tubulin polymerization inhibitors, although none has yet been successfully developed clinically. We report here a new series of related compounds, modified according to a strategy of reducing aromatic ring count and introducing a greater degree of saturation, which retain potent tubulin polymerization activity but with a distinct SAR from previously documented libraries. A subset of active compounds from the reported series is shown to interact with tubulin at the colchicine binding site, disrupt the cellular microtubule network, and exert a cytotoxic effect against multiple cancer cell lines. Two compounds demonstrated significant tumor growth inhibition in a mouse xenograft model of head and neck cancer, a type of the disease which often proves resistant to chemotherapy, supporting further development of the current series as potential new therapeutics.
• Characterization of Maleimide-Based Glycogen Synthase Kinase-3 (GSK-3) Inhibitors as Stimulators of Steroidogenesis
  作者：Hendra Gunosewoyo、Andrew Midzak、Irina N. Gaisina、Emily V. Sabath、Allison Fedolak、Taleen Hanania、Dani Brunner、Vassilios Papadopoulos、Alan P. Kozikowski

  DOI：10.1021/jm400511s

  日期：2013.6.27

  Inhibition of GSK-3 beta has been well documented to account for the behavioral actions of the mood stabilizer lithium in various animal models of mood disorders. Recent studies have showed that genetic or pharmacological inhibition of GSK-3 beta resulted in anxiolytic-like and pro-social behavior. In our ongoing efforts to develop GSK-3 beta inhibitors for the treatment of mood disorders, SAR studies on maleimide-based compounds were undertaken. We present herein for the first time that some of these GSK-3 beta inhibitors, in particular analogues 1 and 9, were able to stimulate progesterone production in the MA-10 mouse tumor Leydig cell model of steroidogenesis without any significant toxicity. These two compounds were tested in the SmartCube behavioral assay and showed anxiolytic-like signatures following daily dose administration (50 mg/kg, ip) for 13 days. Taken together, these results support the hypothesis that GSK-3 beta inhibition could influence neuroactive steroid production thereby mediating the modulation of anxiety-like behavior in vivo.
• Synthesis, antitumor activity and CDK1 inhibiton of new thiazole nortopsentin analogues
  作者：Barbara Parrino、Alessandro Attanzio、Virginia Spanò、Stella Cascioferro、Alessandra Montalbano、Paola Barraja、Luisa Tesoriere、Patrizia Diana、Girolamo Cirrincione、Anna Carbone

  DOI：10.1016/j.ejmech.2017.06.052

  日期：2017.9

  A new series of thiazole nortopsentin analogues was conveniently synthesized with fair overall yields. The antiproliferative activity of the new derivatives was tested against different human tumor cell lines of the NCI full panel. Four of them showed good antitumor activity with GI50 values from micro to nanomolar level. The mechanism of the antiproliferative effect of these derivatives, was pro-apoptotic

  方便地合成了一系列新的噻唑降钙素原类似物，总收率很高。测试了新衍生物对NCI全图的不同人类肿瘤细胞系的抗增殖活性。其中四个显示出良好的抗肿瘤活性，GI 50值从微摩尔到纳摩尔水平。这些衍生物的抗增殖作用的机制是促凋亡的，与质膜磷脂酰丝氨酸的外在化和DNA片段化有关。新噻唑类化合物中最具活性和选择性的是将活细胞限制在G2 / M期，并显着抑制了体外CDK1活性。
• Potent Platelet-Derived Growth Factor-.BETA. Receptor (PDGF-.BETA.R) Inhibitors: Synthesis and Structure-Activity Relationships of 7-[3-(Cyclohexylmethyl)ureido]-3-{1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl}quinoxalin-2(1H)-one Derivatives
  作者：Katsuyuki Aoki、Tatsuhiro Obata、Yosuke Yamazaki、Yoshikazu Mori、Hiroko Hirokawa、Jun-ichi Koseki、Tomohisa Hattori、Kazuaki Niitsu、Shuichi Takeda、Masaki Aburada、Ken-ichi Miyamoto

  DOI：10.1248/cpb.55.255

  日期：——

  previously that 7-[3-(cyclohexylmethyl)ureido]-3-1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl}quinoxalin-2(1H)-one (7d-6) has considerable potency as a PDGF inhibitor. This compound showed potent inhibitory activity in a PDGF-induced CPA (Cell Proliferation Assay) and APA (Auto-Phosphorylation Assay) (IC50 = 0.05 micromol/l in CPA, 0.03 micromol/l in APA). Therefore, we tried to develop a novel and effective

  我们先前发现7- [3-（环己基甲基）脲基] -3- 1-甲基-1H-吡咯并[2,3-b]吡啶-3-基}喹喔啉-2（1H）-一（7d-6 ）作为PDGF抑制剂具有相当大的潜力。该化合物在PDGF诱导的CPA（细胞增殖测定）和APA（自磷酸化测定）中表现出有效的抑制活性（C50中的IC50 = 0.05 micromol / l，APA中的0.03 micromol / l）。因此，我们试图通过优化其一系列衍生物来开发新颖有效的PDGF-βR抑制剂。我们发现三氟乙酸（TFA）催化吡咯并[2,3-b]吡啶与喹喔啉-2-酮的偶联在温和的氧化条件下有效地进行了氧化锰（IVO）的原位反应，因此该方法得以应用准备一系列衍生物。对新合成衍生物进行体外筛选的结果表明，化合物7d-9具有强效性（CPA中的IC50 = 0.014 micromol / l，APA中的0.007 micromol / l）和